US Edition
Gilead Sciences sets $32bn plan for AI-geared pharma factories in the US
Summary by RCR Wireless News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Gilead Sciences sets $32bn plan for AI-geared pharma factories in the US
Gilead Sciences is building an AI-enabled lab in Foster City, California, as the first part of a $32bn investment scheme that includes a number of a new high-tech Industry 4.0 constructions. Due to open in 2026, the site will drive oncology and inflammation research while boosting US biopharma growth. In sum – what to know: […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
